GENE ONLINE|News &
Opinion
Blog

PRNewswire
First Patient Dosed in Phase II Renal Cancer Theranostics Study
2022-05-04
The Danish National Genome Center Partners with Lifebit to Deliver Nationwide Personalised Medicine
2022-04-28
FDA Approves Direct Biologics to Proceed with a Landmark Phase 3 Acute Respiratory Distress Syndrome (ARDS) Trial
2022-04-26
Octapharma to address unmet needs in von Willebrand disease as a proud sponsor of WFH 2022 World Congress
2022-04-26
DetectedX and GE Healthcare Enter Mammography Education Partnership to Improve Accuracy and Better Inform Clinical Decisions
2022-04-25
FDA granted CMG901 Fast Track Designation for unresectable or metastatic gastric and gastroesophageal junction cancer which have relapsed and/or are refractory to approved therapies
2022-04-19
Ascletis Announces 3CLpro Inhibitor ASC11 Demonstrated Potential to be Effective Treatment for COVID-19
2022-04-19
A Brainwave Technology from Hyundai Mobis Proven to Reduce Drowsiness and Inattentive Driving by Up to 1/3
2022-04-18
WHO report highlights the role of Traditional Chinese Medicine in the treatment of COVID-19
2022-04-18
World Hemophilia Day 2022 – “Access for All: Partnership. Policy. Progress. Engaging your government, integrating inherited bleeding disorders into national policy”
2022-04-17
Fosun Diagnostics Receives China NMPA Approval for Its Independently Developed Novel Coronavirus Antigen Detection Kit
2022-04-16
AACR 2022: Ascentage Pharma Presents Latest Results from Six Preclinical Studies
2022-04-13
Sciwind Biosciences Announces Initiation of Dosing in Phase 1 Clinical Trial Evaluating XW004, an oral tablet formulation of its Proprietary GLP-1 Analogue (Ecnoglutide)
2022-04-13
111, Inc. Provides Urgently-needed Items and Online Services to Support Shanghai’s Fight Against Covid-19 Pandemic
2022-04-13
CStone Announces Presentation of Preclinical data on a Multi-Specific Antibody-based Therapeutic Candidate CS2006/NM21-1480 at the American Association for Cancer Research (AACR) Annual Meeting 2022
2022-04-12
1 12 13 14 15 16
LATEST
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
EVENT
Scroll to Top